Practitioner product
Summary
- Features Palmitoylethanolamide (PEA) from Levagen+TM a fatty acid amide with quercetin dihydrate
- Utilises LipiSperse® technology to enhance water solubility and absorption
- May help to reduce mild nerve pain and neuralgia
- No artificial colours, flavours or preservatives
- No added nuts, soy or dairy
Dosage
- 1 - 2 capsules daily
Warnings
- Adults only
- Always read the label
- Dietary supplements should not replace a balanced diet
- If symptoms persist, worsen or change unexpectedly, consult your healthcare professional
- Not to be used for more than 21 consecutive days
- May interact with other prescription analgesic medicines
Formula
| Ingredient |
1 capsule
|
|---|---|
| Levagen™ with LipiSperse® Palmitoylethanolamide (PEA) | 300 mg |
| Quercetin dihydrate | 30 mg |
Downloads
TGA listed: AustL 374580. The TGA publishes product info including excipients under the "Other ingredients" subheading (not typically listed on the product label). Learn more about excipients
